BOPA Equity, Diversity and Inclusion (EDI) Code of Conduct Policy and Policy Statement

BOPA is committed to building a diverse, equitable and inclusive community for all members, non-members and patients in cancer care.  The British Oncology Pharmacy Association (BOPA) has produced a code of conduct for all BOPA members, to promote a culture of equity, diversity and inclusion (EDI) within the organisation.  We have also produced BOPA Policy Statement for Equity, Diversity and Inclusion.

This information can be found on the EDI Subcommittee page here: https://www.bopa.org.uk/membergroups/subcommittee/equality-diversity-and-inclusion-sub-committee/ or via the resource section here: https://www.bopa.org.uk/resources/?_sft_resource-tags=equity-diversity-and-inclusion-subcommittee

 

Latest News

By BOPA E&T Subcommittee on 9th December 2025

BOPA Introduction to Cancer Course, Scotland, March 2026 – registration now OPEN!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA Research Committee on 7th December 2025

BOPA-PRUK Research Award – NOW OPEN for Applications 2026

The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026.  BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…

Read article
By BOPA Research Subcommittee on 2nd December 2025

AI in Oncology Survey

The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…

Read article
By BOPA Research Sub Committee on 2nd December 2025

Project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services

Dear Colleagues, The University of Birmingham and University Hospitals Birmingham are jointly conducting a project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services. We…

Read article